US Patent Issued to TSP Therapeutics on Aug. 25 for "Histamine receptor agonists for cancer therapy in cancer patients unresponsive to cancer immunotherapy and with elevated myeloid derived suppressor cells" (Florida Inventor)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,695, issued on Aug. 25, was assigned to TSP Therapeutics Inc. (Indian Rocks Beach, Fla.).

"Histamine receptor agonists for cancer therapy in cancer patients unresponsive to cancer immunotherapy and with elevated myeloid derived suppressor cells" was invented by Alberto Paz (Indian Rocks Beach, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are formulations of histamine and histamine receptor agonists for treating a cancer or a tumor. Also disclosed are methods of using myeloid derived suppressor cell (MDSC) detection assays to select cancer patients for treatment with the formulations as disclosed herein. Also disclosed are met...